337
Views
6
CrossRef citations to date
0
Altmetric
Review

Phosphorus-containing nanoparticles: biomedical patents review

, , , , & (Professor, Head of the Department of General Biophysics)

Bibliography

  • Geckeler KE, Rosenberg E, editors. Functional nanomaterials. Amer Scientific Pub, Valencia; 2006
  • Kievit F, Zhang M. Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers. Adv Mater 2011;23:H217-47
  • Shcharbina N, Shcharbin D, Bryszewska M. Nanomaterials in stroke treatment: perspectives. Stroke 2013;44:2351-5
  • Hammond CR. The Elements. In: Lide DR, editor. Handbook of chemistry and physics. 81st edition. CRC press London; 2000
  • Corbridge D. Phosphorus: an outline of its chemistry, biochemistry, and technology. Elsevier, Amsterdam; 1995
  • Nelson D, Cox M. Lehningers principles of biochemistry. 3rd edition. Worth Publishing, New York; 2000
  • Gebel T, Foth H, Damm G, et al. Manufactured nanomaterials: categorization and approaches to hazard assessment. Arch Toxicol 2014;88(12):2191-211
  • Kunzmann A, Andersson B, Thurnherr T, et al. Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta 2011;1810:361-73
  • Peterson EC, Nanaware-Kharade N, Gonzalez GIII. Preparation of anti-Meth single chain scFv antibody-nanoparticle conjugates for treatment of drug abuse. WO160075; 2014
  • Cui J, Chen L, Zhu L. Antigen presenting cell targeting nanoparticles and preparation thereof. CN101716345; 2010
  • Prandi J, Puzo G, Turrin CO, et al. Dendrimers with a saccharide ending for anti-inflammatory purposes. WO089945; 2012
  • Poupot M, Poupot R, Fournie J-J, et al. Phosphorylated dendrimers as antiinflammatory drugs. US0173871, WO013086;2010
  • Poupot M, Poupot R, Fournie J-J, et al. Phosphorylated dendrimers as antiinflammatory drugs. US0336997; 2013
  • Raghavan PR. Metadichol liquid and gel nanoparticle formulations. WO150609; 2014
  • Gref R, Agostoni V, Daoud-Mahammed S, et al. Preparation of improved organic-inorganic hybrid solid with the outer surface modified with a pharmaceutical agent for use in medicine. WO178954; 2013
  • Pop CV. Transport and delivery of glutathione into human cells using gold nanoparticles. US0111002; 2011
  • Kwong KF, Tobin LA. Nanoparticles with enhanced entry into cancer cells. WO173693; 2013
  • Wang JP, Jing Y, He SH. Biodegradable magnetic nanoparticles and related methods. US0243699; 2013
  • Bensaoula A, Boney J, Beddar A, et al. Use of nanoparticles in the photodynamic treatment of tumors. US8328785; 2012
  • Wang J, Sun T, Du J. Medical carrier of polyethylene glycol monomethyl ether-polycaprolactone-polyphosphate triblock copolymer positively charged nanoparticles, its preparation process and application. CN101766817; 2010
  • Wang J, Xiong M, Wu J. Biocompatible nanoparticle applicable to drug delivery carrier. CN101732721; 2010
  • Nam JM, Lee JH, Oh JW. Gold or silver nanoparticles in the shape of nanosnowman with a head part and a body part, a preparation method thereof and a detection method using laser excitation and Raman spectroscopy. KR124182; 2013
  • Chae GY, Lu CH. Contrast agent with excellent stability and biocompatibility containing phosphate-polymer coated iron oxide nanoparticles, and method for manufacturing the same. KR113822; 2013
  • Chakravarthy K, Kamisetti S. Nanoparticles and assay kits for identifying presence of biological markers. US0123145; 2013
  • Kang W. Antimicrobial coating compositions for pads. KR100394; 2013
  • Huang Q, Fan CH, Hu W, et al. Application of graphene oxide nanoparticle as antibacterial agent. CN101990899; 2011
  • Treseder KK, Whiteside MD. Nanotechnological delivery of microbicides and other substances. WO031487; 2011
  • Cui ZH, Lansakara P, Dharmika SP, et al. Gemcitabine lipophilic monophosphorylated derivatives of and nanoparticles for treating cancer or viral infection. US0131008; 2013
  • Zhao Y. Nanoparticles and organic nanoparticle with surface crosslinked nonpolymeric organic amphiphiles. US0101516; 2013
  • Hong Y, Tan CH. Manufacture of bioactive glass nanofibers containing calcium phosphate nanoparticles. CN102826760; 2012
  • Shukla BA, Craig BD. Adhesive composition suitable for dental uses. WO064573; 2012
  • Yang X, Fang ZH, Liu H, et al. Core/shell ferroferric oxide/calcium phosphate nanoparticles used in cell regulation and bone repair under magnetic field action and preparation method thereof. CN101721749A; 2010
  • Zhang Y, Wu CH, Luo T. B-containing nanometer mesoporous/macroporous bioactive glass, its preparation method and application in tissue engineering scaffolding. CN102557398; 2012
  • Beck-Broichsitter M, Schmehl T, Gessler T, et al. Biocompatible polymeric nanoparticles comprising active ingredients for pulmonary application. US012731; 2014
  • Chiou P-Y, Wu T-H, Butt SK, et al. Photothermal substrates for selective transfection of cells. WO158631; 2012
  • Shcharbin D, Dzmitruk V, Shakhbazau A, et al. Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier. Pharmaceutics 2011;3:458-73
  • Shakhbazau AV, Shcharbin DG, Goncharova NV, et al. Neurons and stromal stem cells as targets for polycation-mediated transfection. Bull Exp Biol Med 2011;151:126-9
  • Wang D, Zhang P, Wang J, et al. Method for manufacturing enzyme sensor for detecting organic phosphorus pesticide. CN102890112; 2011
  • Tarafdar JCH, Raliya R. Biosynthesis of metal nanoparticle from fungi. INDE00149; 2012
  • Kottegoda N, Priyadharshana G, Sandaruwan CH, et al. Composition and method for sustained release of agricultural macronutrients. US0098125; 2013
  • Madani SY, Naderi N, Dissanayake O, et al. A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine 2011;6:2963-79
  • Tomalia DA. Dendritic effects: dependency of dendritic nano-periodic property patterns on critical nanoscale design parameters (CNDPs). New J Chem 2012;36:264-81
  • Menjoge AR, Kannan RM, Tomalia DA. Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discov Today 2010;15:171-85
  • Kannan RM, Nance E, Kannan S, et al. Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications. J Intern Med 2014;276(6):579-617
  • Shcharbin D, Shcharbina N, Bryszewska M. Recent patents in dendrimers for nanomedicine: evolution 2014. Recent Pat Nanomedicine 2014;4:25-31
  • Shcharbin D, Janaszewska A, Klajnert-Maculewicz B, et al. How to study dendrimers and dendriplexes III. Biodistribution, pharmacokinetics and toxicity in vivo. J Control Release 2014;181:40-52
  • Shcharbin D, Shakhbazau A, Bryszewska M. Poly(amidoamine) dendrimer complexes as a platform for gene delivery. Exp Opin Drug Deliv 2013;10:1687-98
  • Mout R, Moyano DF, Rana S, et al. Surface functionalization of nanoparticles for nanomedicine. Chem Soc Rev 2012;41:2539-44
  • Senior JH. Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst 1987;3:123-93
  • World Health Statistics 2013. Available from: http://www.who.int/gho/publications/world_health_statistics/2013/en/ [Last accessed 23 October 2014]
  • Krug HF. Nanosafety research-are we on the right track? Angew Chem Int Ed Engl 2014;53(46):12304-19

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.